Related Experiment Video
Updated: Mar 10, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
An emerging evidence base for the management of neonatal hypoglycaemia
Jane E Harding1, Deborah L Harris2, Joanne E Hegarty3
1Liggins Institute, University of Auckland, 85 Park Ave, Grafton, Auckland 1023, New Zealand.
Insights
Neonatal hypoglycemia is common, but management decisions lack evidence. Dextrose gel shows promise for treatment, but optimal intervention thresholds and long-term outcomes require further research.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
Background:
- Neonatal hypoglycemia is a common condition in newborns.
- Current screening and treatment practices lack robust evidence-based guidelines.
- Uncertainty exists regarding optimal diagnostic thresholds, treatment strategies, and long-term outcomes.
Purpose of the Study:
- To review the current understanding of neonatal hypoglycemia management.
- To highlight the need for evidence-based guidelines for screening and treatment.
- To emphasize the necessity of further research into optimal intervention thresholds and treatment efficacy.
Main Methods:
- Review of recent studies on neonatal hypoglycemia.
- Analysis of evidence regarding risk factors and treatment options.
- Identification of gaps in current knowledge and research needs.
Main Results:
- Dextrose gel has emerged as a potentially safe and effective treatment, supporting breastfeeding.
- Babies with glycemic instability and low glucose concentrations may face higher risks of later cognitive and learning problems.
- Optimal intervention thresholds and treatment strategies remain uncertain.
Conclusions:
- There is a critical need for randomized trials to establish evidence-based guidelines for neonatal hypoglycemia management.
- Further research should focus on defining optimal intervention thresholds and effective treatment strategies.
- Ensuring infant safety and addressing long-term neurodevelopmental outcomes are paramount.
Abstract:
Neonatal hypoglycaemia is common, and screening and treatment of babies considered at risk is widespread, despite there being little reliable evidence upon which to base management decisions. Although there is now evidence about which babies are at greatest risk, the threshold for diagnosis, best approach to treatment and later outcomes all remain uncertain. Recent studies suggest that treatment with dextrose gel is safe and effective and may help support breast feeding. Thresholds for intervention require a wide margin of safety in light of information that babies with glycaemic instability and with low glucose concentrations may be associated with a higher risk of later higher order cognitive and learning problems. Randomised trials are urgently needed to inform optimal thresholds for intervention and appropriate treatment strategies.
Related Concept Videos
01:15Hypoglycemia and Glucagon
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:14SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
01:22Diabetes Mellitus: Type 2 and Gestational
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...